ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

July 25, 2003

Two-Month Longer Survival Found With Gliadel Wafer

March 31, 2006

Clearinghouse Asks Short Term Test Use To Help In Chemical Selection

September 17, 1977

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

October 13, 1978

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014